Cite
MLA Citation
Vimalanand S Prabhu et al.. “Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection.” Clinical infectious diseases, vol. 66, 2018, pp. 355–362. http://access.bl.uk/ark:/81055/vdc_100095200168.0x00002c